BGLAF
Price
$9.58
Change
-$0.92 (-8.76%)
Updated
Dec 3 closing price
Capitalization
1B
DHBUF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
3.81M
Ad is loading...

BGLAF vs DHBUF

Header iconBGLAF vs DHBUF Comparison
Open Charts BGLAF vs DHBUFBanner chart's image
Biogaia AB
Price$9.58
Change-$0.92 (-8.76%)
Volume$2.65K
Capitalization1B
DELIVRA HEALTH BRANDS
Price$0.01
Change-$0.00 (-0.00%)
Volume$30.43K
Capitalization3.81M
BGLAF vs DHBUF Comparison Chart
Loading...
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHBUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BGLAF vs. DHBUF commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGLAF is a Hold and DHBUF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (BGLAF: $9.58 vs. DHBUF: $0.01)
Brand notoriety: BGLAF and DHBUF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BGLAF: 134% vs. DHBUF: 75%
Market capitalization -- BGLAF: $1B vs. DHBUF: $3.81M
BGLAF [@Pharmaceuticals: Other] is valued at $1B. DHBUF’s [@Pharmaceuticals: Other] market capitalization is $3.81M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BGLAF’s FA Score shows that 2 FA rating(s) are green whileDHBUF’s FA Score has 0 green FA rating(s).

  • BGLAF’s FA Score: 2 green, 3 red.
  • DHBUF’s FA Score: 0 green, 5 red.
According to our system of comparison, BGLAF is a better buy in the long-term than DHBUF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BGLAF’s TA Score shows that 1 TA indicator(s) are bullish while DHBUF’s TA Score has 1 bullish TA indicator(s).

  • BGLAF’s TA Score: 1 bullish, 1 bearish.
  • DHBUF’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, BGLAF is a better buy in the short-term than DHBUF.

Price Growth

BGLAF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while DHBUF (@Pharmaceuticals: Other) price change was -8.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BGLAF($1B) has a higher market cap than DHBUF($3.81M). BGLAF YTD gains are higher at: 0.000 vs. DHBUF (-10.638). BGLAF has higher annual earnings (EBITDA): 529M vs. DHBUF (-1.85M). BGLAF has more cash in the bank: 1.37B vs. DHBUF (2.93M). BGLAF has higher revenues than DHBUF: BGLAF (1.21B) vs DHBUF (8.4M).
BGLAFDHBUFBGLAF / DHBUF
Capitalization1B3.81M26,266%
EBITDA529M-1.85M-28,657%
Gain YTD0.000-10.638-
P/E Ratio25.58N/A-
Revenue1.21B8.4M14,447%
Total Cash1.37B2.93M46,790%
Total DebtN/A1.9M-
FUNDAMENTALS RATINGS
DHBUF: Fundamental Ratings
DHBUF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
84
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
46

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BGLAFDHBUF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bullish Trend 12 days ago
60%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
28%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
29%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 20 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 12 days ago
32%
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Ad is loading...
BGLAF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DHBUF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEEAX15.630.10
+0.64%
PGIM Jennison Mid-Cap Growth A
AUXFX29.470.15
+0.51%
Auxier Focus Inv
DDDRX14.910.07
+0.47%
Macquarie Wealth Builder R
VEVRX47.380.08
+0.17%
Victory Sycamore Established Value R6
RECRX11.930.02
+0.17%
RBC Emerging Markets Ex-China Equity R6

BGLAF and

Correlation & Price change

A.I.dvisor tells us that BGLAF and SNOA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BGLAF and SNOA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BGLAF
1D Price
Change %
BGLAF100%
N/A
SNOA - BGLAF
30%
Poorly correlated
-0.38%
CTTH - BGLAF
28%
Poorly correlated
+35.54%
CRYM - BGLAF
22%
Poorly correlated
N/A
SHPH - BGLAF
8%
Poorly correlated
-4.62%
DHBUF - BGLAF
5%
Poorly correlated
-0.94%
More

DHBUF and

Correlation & Price change

A.I.dvisor tells us that DHBUF and EAPIF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DHBUF and EAPIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DHBUF
1D Price
Change %
DHBUF100%
-0.94%
EAPIF - DHBUF
10%
Poorly correlated
N/A
CNADF - DHBUF
7%
Poorly correlated
N/A
BGLAF - DHBUF
5%
Poorly correlated
N/A
CLSH - DHBUF
5%
Poorly correlated
N/A
ESAIY - DHBUF
2%
Poorly correlated
+1.96%
More